Data as of 10:26am ET
| +0.01 / +0.14%|
The 4 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 15.50, with a high estimate of 20.00 and a low estimate of 12.00. The median estimate represents a +115.28% increase from the last price of 7.20.
The current consensus among 4 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.